Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

The Current Landscape of Immune Checkpoint Inhibition for Solid Malignancies.

Keung EZ, Wargo JA.

Surg Oncol Clin N Am. 2019 Jul;28(3):369-386. doi: 10.1016/j.soc.2019.02.008. Review.

PMID:
31079794
2.

Window-of-Opportunity Trials: The Road Forward in Soft Tissue Sarcoma and Beyond.

Keung EZ, Roland CL.

Ann Surg Oncol. 2019 May;26(5):1188-1189. doi: 10.1245/s10434-019-07193-2. Epub 2019 Jan 24. No abstract available.

PMID:
30680475
3.

Accurate and Reproducible Diagnosis of Canine Soft Tissue Sarcoma Using Mass Spectrometry: A Step in the Right Direction.

Keung EZ, Roland CL.

Cancer Cell. 2018 Nov 12;34(5):697-699. doi: 10.1016/j.ccell.2018.10.013.

PMID:
30423292
4.

Treatment at low-volume hospitals is associated with reduced short-term and long-term outcomes for patients with retroperitoneal sarcoma.

Keung EZ, Chiang YJ, Cormier JN, Torres KE, Hunt KK, Feig BW, Roland CL.

Cancer. 2018 Dec 1;124(23):4495-4503. doi: 10.1002/cncr.31699. Epub 2018 Oct 14.

PMID:
30317543
5.

Phase II study of neoadjuvant checkpoint blockade in patients with surgically resectable undifferentiated pleomorphic sarcoma and dedifferentiated liposarcoma.

Keung EZ, Lazar AJ, Torres KE, Wang WL, Cormier JN, Ashleigh Guadagnolo B, Bishop AJ, Lin H, Hunt KK, Bird J, Lewis VO, Patel SR, Wargo JA, Somaiah N, Roland CL.

BMC Cancer. 2018 Sep 24;18(1):913. doi: 10.1186/s12885-018-4829-0.

6.

Engineered T Cells in Synovial Sarcoma: Persistence Pays Off!

Keung EZ, Tawbi HA.

Cancer Discov. 2018 Aug;8(8):914-917. doi: 10.1158/2159-8290.CD-18-0618.

PMID:
30076141
7.

The eighth edition American Joint Committee on Cancer (AJCC) melanoma staging system: implications for melanoma treatment and care.

Keung EZ, Gershenwald JE.

Expert Rev Anticancer Ther. 2018 Aug;18(8):775-784. doi: 10.1080/14737140.2018.1489246. Review.

PMID:
29923435
8.

The clinical behavior of well differentiated liposarcoma can be extremely variable: A retrospective cohort study at a major sarcoma center.

Keung EZ, Ikoma N, Benjamin R, Wang WL, Lazar AJ, Feig BW.

J Surg Oncol. 2018 Jun;117(8):1799-1805. doi: 10.1002/jso.25082. Epub 2018 May 3.

PMID:
29723411
9.

The Rationale and Emerging Use of Neoadjuvant Immune Checkpoint Blockade for Solid Malignancies.

Keung EZ, Ukponmwan EU, Cogdill AP, Wargo JA.

Ann Surg Oncol. 2018 Jul;25(7):1814-1827. doi: 10.1245/s10434-018-6379-8. Epub 2018 Mar 2.

PMID:
29500764
10.

Analysis of the immune infiltrate in undifferentiated pleomorphic sarcoma of the extremity and trunk in response to radiotherapy: Rationale for combination neoadjuvant immune checkpoint inhibition and radiotherapy.

Keung EZ, Tsai JW, Ali AM, Cormier JN, Bishop AJ, Guadagnolo BA, Torres KE, Somaiah N, Hunt KK, Wargo JA, Lazar AJ, Wang WL, Roland CL.

Oncoimmunology. 2017 Oct 31;7(2):e1385689. doi: 10.1080/2162402X.2017.1385689. eCollection 2018.

11.

Defining the incidence and clinical significance of lymph node metastasis in soft tissue sarcoma.

Keung EZ, Chiang YJ, Voss RK, Cormier JN, Torres KE, Hunt KK, Feig BW, Roland CL.

Eur J Surg Oncol. 2018 Jan;44(1):170-177. doi: 10.1016/j.ejso.2017.11.014. Epub 2017 Nov 27.

12.

Systematic Epigenomic Analysis Reveals Chromatin States Associated with Melanoma Progression.

Fiziev P, Akdemir KC, Miller JP, Keung EZ, Samant NS, Sharma S, Natale CA, Terranova CJ, Maitituoheti M, Amin SB, Martinez-Ledesma E, Dhamdhere M, Axelrad JB, Shah A, Cheng CS, Mahadeshwar H, Seth S, Barton MC, Protopopov A, Tsai KY, Davies MA, Garcia BA, Amit I, Chin L, Ernst J, Rai K.

Cell Rep. 2017 Apr 25;19(4):875-889. doi: 10.1016/j.celrep.2017.03.078.

13.

Management of Gastrointestinal Stromal Tumors.

Keung EZ, Raut CP.

Surg Clin North Am. 2017 Apr;97(2):437-452. doi: 10.1016/j.suc.2016.12.001. Review.

PMID:
28325196
14.

Surgical Management of Metastatic Disease.

Keung EZ, Fairweather M, Raut CP.

Surg Clin North Am. 2016 Oct;96(5):1175-92. doi: 10.1016/j.suc.2016.05.010. Review.

PMID:
27542649
15.

H3K9me3-mediated repression of KLF6: Discovering a novel tumor suppressor in liposarcoma using a systematic epigenomic approach.

Keung EZ, Rai K.

Mol Cell Oncol. 2015 Oct 29;3(3):e1093691. doi: 10.1080/23723556.2015.1093691. eCollection 2016 May.

16.

The Role of Surgery in Metastatic Gastrointestinal Stromal Tumors.

Keung EZ, Fairweather M, Raut CP.

Curr Treat Options Oncol. 2016 Feb;17(2):8. doi: 10.1007/s11864-015-0384-y. Review.

PMID:
26820287
17.

Dual Roles of RNF2 in Melanoma Progression.

Rai K, Akdemir KC, Kwong LN, Fiziev P, Wu CJ, Keung EZ, Sharma S, Samant NS, Williams M, Axelrad JB, Shah A, Yang D, Grimm EA, Barton MC, Milton DR, Heffernan TP, Horner JW, Ekmekcioglu S, Lazar AJ, Ernst J, Chin L.

Cancer Discov. 2015 Dec;5(12):1314-27. doi: 10.1158/2159-8290.CD-15-0493. Epub 2015 Oct 8.

18.

Increased H3K9me3 drives dedifferentiated phenotype via KLF6 repression in liposarcoma.

Keung EZ, Akdemir KC, Al Sannaa GA, Garnett J, Lev D, Torres KE, Lazar AJ, Rai K, Chin L.

J Clin Invest. 2015 Aug 3;125(8):2965-78. doi: 10.1172/JCI77976. Epub 2015 Jul 20.

19.

Predictors of outcomes in patients with primary retroperitoneal dedifferentiated liposarcoma undergoing surgery.

Keung EZ, Hornick JL, Bertagnolli MM, Baldini EH, Raut CP.

J Am Coll Surg. 2014 Feb;218(2):206-17. doi: 10.1016/j.jamcollsurg.2013.10.009. Epub 2013 Oct 25.

PMID:
24315890
20.

Immunocompromised status in patients with necrotizing soft-tissue infection.

Keung EZ, Liu X, Nuzhad A, Adams C, Ashley SW, Askari R.

JAMA Surg. 2013 May;148(5):419-26. doi: 10.1001/jamasurg.2013.173.

PMID:
23677405
21.

External validation of a prognostic nomogram for overall survival in women with uterine leiomyosarcoma.

Iasonos A, Keung EZ, Zivanovic O, Mancari R, Peiretti M, Nucci M, George S, Colombo N, Carinelli S, Hensley ML, Raut CP.

Cancer. 2013 May 15;119(10):1816-22. doi: 10.1002/cncr.27971. Epub 2013 Mar 1.

22.

Concise review: genetically engineered stem cell therapy targeting angiogenesis and tumor stroma in gastrointestinal malignancy.

Keung EZ, Nelson PJ, Conrad C.

Stem Cells. 2013 Feb;31(2):227-35. doi: 10.1002/stem.1269. Review.

23.

In-hospital and long-term outcomes after percutaneous endoscopic gastrostomy in patients with malignancy.

Keung EZ, Liu X, Nuzhad A, Rabinowits G, Patel V.

J Am Coll Surg. 2012 Dec;215(6):777-86. doi: 10.1016/j.jamcollsurg.2012.08.013. Epub 2012 Sep 19.

PMID:
22999329
24.

BRCA1-related papillary serous carcinoma of the peritoneum has a unique molecular pathogenesis.

Schorge JO, Muto MG, Lee SJ, Huang LW, Welch WR, Bell DA, Keung EZ, Berkowitz RS, Mok SC.

Cancer Res. 2000 Mar 1;60(5):1361-4.

Supplemental Content

Loading ...
Support Center